Geron reported $-12454000 in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Amgen USD 2.66B 1.37B Jun/2025
Bio Techne USD -23860000 62.57M Jun/2025
Cassava Sciences USD -14090000 15.4M Jun/2025
Cytokinetics USD -111506000 44.12M Jun/2025
Exelixis USD 215.68M 28.82M Jul/2025
Genmab DKK 360M 172M Jun/2025
Geron USD -12454000 4.25M Jun/2025
Gilead Sciences USD 2.7B 467M Jun/2025
Incyte USD 310.82M 105.66M Jun/2025
MacroGenics USD -36760000 20.17M Jun/2025
Novartis USD 4.86B 201M Jun/2025